ACHP Welcomes Recommendations from National Academies Report on the Affordability of Rx Drugs

FOR IMMEDIATE RELEASE
Contact: Leah Hunter lhunter@achp.org

ACHP Welcomes Recommendations from National Academies Report on the Affordability of Rx Drugs

Washington, D.C. (November 30, 2017) –ACHP welcomes a new report from the National Academies of Sciences, Engineering, and Medicine that aims to improve the affordability of prescription drugs while encouraging innovation to address health care needs.

“We are pleased to see the National Academy make sensible recommendations to improve patient access to affordable treatments, increase transparency in drug pricing and create competition in the market,” said Ceci Connolly, President and CEO of the Alliance of Community Health Plans. “ACHP is dedicated to ensuring a high quality health care system that works for patients and health plans alike.”

Entitled Making Medicines Affordable: A National Imperative, the report recommends policy actions on drug pricing, entry of generics and biosimilars into the market, financial transparency in the supply chain and insurance benefit designs. The new report adds to the growing consensus that stronger public policies are necessary to stop the escalation in drug prices.

ACHP has long been committed to increased transparency in drug pricing, including the disclosure of research and development costs for drug manufacturing, and believes that transparency is a critical first step in creating a competitive and effective pharmaceuticals market. ACHP has endorsed the bipartisan Fair Accountability and Innovative Research Drug Pricing Act of 2017 which would require disclosure from drug manufacturers to provide more information about drug price increases and reporting of research and development costs. ACHP also believes in the availability and affordability of generic drugs and incentivizing competition for additional drugs to enter the market, supporting the bipartisan Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act to targets abusive delay tactics that are being used to block entry of affordable generic drugs.

ACHP’s infographic series highlights drug cost trends for widely prescribed drugs within various therapeutic classes and communicates the potential effect of these prices on key stakeholders.

About ACHP
The Alliance of Community Health Plans (ACHP) is a national leadership organization bringing together innovative health plans and provider groups that are among America’s best at delivering affordable, high-quality coverage and care. ACHP’s member health plans provide coverage and care for more than 19 million Americans across 27 states and the District of Columbia. These organizations focus on improving the health of the communities they serve and are on the leading edge of innovations in affordability and quality of care, including primary care redesign, payment reform, accountable health care delivery and use of information technology. To learn more, go to www.achp.org and follow ACHP on Twitter @_ACHP.